Back to funds

Aisling Capital Management LP

hedge fundUpdated 10 days ago

Managed by Aisling Capital Management Lp • Latest filing Q3 2026

Portfolio value
$299.3M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$478.9M
Q1 2026$476.3M
Q2 2026$471.6M
Q3 2026$299.3M

Top holdings

14 positions as of Q3 2026

View filing
B

BRIDGEBIO PHARMA INC

Value
$203.3M
Shares
3.09M
% Port
67.92%
S

SYNDAX PHARMACEUTICALS INC

Value
$24.8M
Shares
1.32M
% Port
8.27%
C

COMPASS PATHWAYS PLC

Value
$21.6M
Shares
1.73M
% Port
7.20%
M

MONTE ROSA THERAPEUTICS INC

Value
$18.6M
Shares
1.56M
% Port
6.20%
B

BICARA THERAPEUTICS INC

Value
$10.2M
Shares
548.9K
% Port
3.41%
U

UROGEN PHARMA LTD

Value
$4.4M
Shares
108.0K
% Port
1.47%
?
7.N/A

BRIDGEBIO ONCOLOGY THERAPEUT

Value
$4.1M
Shares
1.02M
% Port
1.38%
E

EUPRAXIA PHARMACEUTICALS INC

Value
$3M
Shares
325.0K
% Port
0.99%
?
9.N/A

BIOMEA FUSION INC

Value
$2.7M
Shares
2.05M
% Port
0.92%
A

ACLARIS THERAPEUTICS INC

Value
$2.3M
Shares
434.5K
% Port
0.76%
S

SCHOLAR ROCK HLDG CORP

Value
$2M
Shares
42.0K
% Port
0.68%
V

VTV THERAPEUTICS INC

Value
$1.8M
Shares
58.8K
% Port
0.61%
M

MARKER THERAPEUTICS INC

Value
$348K
Shares
325.4K
% Port
0.12%
O

ONKURE THERAPEUTICS INC

Value
$241K
Shares
88.6K
% Port
0.08%

Explore